Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN110551035A details high-efficiency iridium catalysis for chiral amines. Offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN112174837B reveals a novel Boc-protected aziridine route for high-purity chiral amine intermediates, offering significant cost reduction and supply chain reliability for asthma drug manufacturing.
Patent CN111194304A details an enzymatic method for high-purity bridged ring intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Novel chiral synthesis route for Nebivolol HCl avoiding expensive raw materials. Ideal for reliable API intermediate suppliers seeking cost-effective scale-up.
Patent CN110551036B details a high-efficiency iridium-catalyzed asymmetric hydrogenation method for chiral amines, offering superior enantioselectivity and industrial scalability for agrochemical intermediates.
Patent CN109678911B details a high-efficiency Rh-catalyzed method for planar chiral ferrocene intermediates, offering superior enantioselectivity and supply chain reliability.
Patent CN110551037B details a high-efficiency iridium/chiral diphosphine system for asymmetric hydrogenation, offering superior enantioselectivity for agrochemical intermediates.
Novel iridium catalyst system enables high-yield asymmetric hydrogenation for metolachlor intermediates, offering scalable cost reduction and supply reliability.
Patent CN114539328B reveals surfactant-promoted route enhancing yield and purity. Delivers supply chain stability and cost efficiency for global buyers.
Novel synthesis of Trk inhibitor intermediate CN104672121B offers higher yield and safety. Reliable supply chain partner for scalable API intermediate manufacturing with cost efficiency.
Patent CN104513117B details copper-catalyzed asymmetric decarboxylation for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharma manufacturing.
Novel CBS-catalyzed synthesis ensures high ee value and yield. Scalable process for antiviral intermediate supply chain stability and cost efficiency.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel cobalt-catalyzed asymmetric double hydroboration for high-purity chiral 1,5-diboron intermediates. Enables cost-effective synthesis of Preclamol and advanced materials.
Novel copper-catalyzed radical coupling method for chiral 3-aminopiperidine. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.
Patent CN116589426B reveals iridium-catalyzed asymmetric synthesis enabling high-purity chiral intermediates with significant supply chain and cost advantages for global pharmaceutical manufacturing.
Patent CN109761984B reveals a novel asymmetric hydrogen transfer method for high-purity chiral purine nucleosides, offering significant cost reduction and supply chain reliability for API manufacturing.